Zydus Cadila to supply doses of Covid-19 jab to Centre by December: Report | Latest News India - Hindustan Times
close_game
close_game

Zydus Cadila to supply 10 million doses of Covid-19 jab to Centre by December: Report

By, New Delhi
Nov 18, 2021 10:22 PM IST

The Centre placed an initial order for 10 million dose of ZyCoV-D with the Ahmedabad-based firm. The initial batch will be used only for adults.

Ahmedabad-based Zydus Cadila, which has developed India’s second indigenous Covid-19 vaccine, ZyCoV-D, will reportedly supply the initial doses of the jab to the central government by December. Also, though the vaccine has been granted emergency use authorisation (EUA) for those aged 12 and above, the first doses will only be for people aged 18 and above, the report said.

Also Read | Zydus jab cleared for kids to cost govt 265

Discover the thrill of cricket like never before, exclusively on HT. Explore now!

“Zydus Cadila’s Covid-19 vaccine for persons above 18 years of age will be supplied to the government by December. The government has placed an initial order for one crore doses of the vaccines,” news agency ANI reported citing government sources.

 

The latest report is in line with that from earlier this month, which stated that the Union government has placed an order for 10 million (1 crore) doses with the vaccine manufacturer. It has also been reported previously that the needle-free jab will be administered to adults first.

Also Read | Govt to buy one crore doses of Zydus Cadila's needle-free Covid-19 vaccine

However, if the initial batch is indeed delivered only by next month, then it would mean an additional delay in including ZyCoV-D in the national inoculation programme, which began on January 16 this year. The shot was approved by the Drugs Controller General of India (DCGI) in August.

The vaccine has a three-dose regime, with a gap of 28 days each between the first and second, and the second and third doses. The first shot will be given on day zero, with the next two to follow on the 28th and 56th day respectively. It is also India’s only coronavirus vaccine to be approved for an age group below 18. However, an inoculation drive for kids is yet to be announced.

Meanwhile, of the other five vaccines granted EUA by the drugs regulator, the only indigenous jab is Covaxin, developed by the Hyderabad-based Bharat Biotech International Limited. ZyCoV-D was the sixth to receive emergency use approval.

 

 

 

Unveiling 'Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch Now!

Get Updates on India News, Farmers Protest Live alongwith the Latest News and Top Headlines from India and around the the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Wednesday, February 21, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On